HepC Micro-elimination on MSM and TGW Population.

This is an observational study, in which a single visit will be carried out, which includes a questionnaire on sexual habits and in which the possibility of carrying out a screening for Hepatitis C will be offered. Depending on the score obtained in the questionnaire, the screening will be carried out using a rapid serology test or viral load. During the first year, a SCORE will be developed to classify the risk of positive results. This SCORE will be used during phase 2 to offer users of the centres a targeted screening based on the Pre-test score.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatitis C Blood-Borne Infections Chemically-Induced Disorders Communicable Diseases Digestive System Diseases Drugs of Abuse Flaviviridae Infections Hepatitis Hepatitis, Viral, Human Infections Liver Diseases Mental Disorders PreP RNA Virus Infections Substance-Related Disorders Virus Diseases

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

BCN checkpoint

Barcelona, 08015, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All BCN Checkpoint and BCN PreP·Point clients.
18 years and older.
HIV uninfected or diagnosticated in the center in the last 7 days prior to the study inclusion.
Men that have sex with men or transgender women.
Signature of written consent form.
Ability to comply with the requirements of the study protocol.

Exclusion criteria

Knowledge of HIV infection from more than 7 days
Knowledge of active HCV infection

Treatment and study plan

Primary outcomes

Hepatitis C active infection

Time frame: August 2021 o September 2023

Confirmed Hepatitis C active infection

Sponsors and collaborators

Lead sponsor

Projecte dels NOMS Hispanosida

Other

Collaborators

Fundació Lluita contra les Infeccions
Germans Trias i Pujol Hospital

Registry information

Official study title

HepC Micro-elimination on MSM Comunity

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Feb 26, 2025
Registry last updated: Feb 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed